Publications by authors named "Stephan Matthaei"

Claim this Profile
G
Gaps and barriers in the control of blood glucose in people with type 2 diabetes.
Lawrence Blonde, Pablo Aschner, Clifford Bailey, Linong Ji, Lawrence A Leiter, Stephan Matthaei

Diab Vasc Dis Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes.
Stephan Matthaei, Doina Catrinoiu, Aleksander Celiński, Ella Ekholm, William Cook

Diabetes Care· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial.
Stephan Matthaei, Keith Bowering, Katja Rohwedder, Anke Grohl, Shamik Parikh

Diabetes Care· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes and cancer: should we prefer antihyperglycaemic treatments without unnecessarily increasing insulin levels?
Stephan Matthaei

Diab Vasc Dis Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE.
Chantal Mathieu, Claes-Göran Ostenson, Stephan Matthaei, Matthew Reaney, Thure Krarup

Diabetes Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.
Matthew Reaney, Chantal Mathieu, Claes-Göran Ostenson, Stephan Matthaei, Thure Krarup

Health Qual Life Outcomes· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.
Clifford J Bailey, Pablo Aschner, Stefano Del Prato, James LaSalle, Linong Ji, Stephan Matthaei

Diab Vasc Dis Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study.
Urpo Kiiskinen, Stephan Matthaei, Matthew Reaney, Chantal Mathieu, Claes-Göran Ostenson

Clinicoecon Outcomes Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries.
Claes-Göran Ostenson, Stephan Matthaei, Matthew Reaney, Thure Krarup, Bruno Guerci

Diabetes Metab Syndr Obes· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study.
Stephan Matthaei, Matthew Reaney, Chantal Mathieu, Claes-Göran Ostenson, Thure Krarup

Diabetes Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study.
Walter Zidek, Joachim Schrader, Stephan Lüders, Stephan Matthaei, Christoph Hasslacher

Cardiovasc Diabetol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Type 2 diabetes: interview with Prof. Stephan Matthaei. Reaching HbA1c target value while preventing hypoglycemia].
Stephan Matthaei

MMW Fortschr Med· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.
Walter Zidek, Joachim Schrader, Stephan Lüders, Stephan Matthaei, Christoph Hasslacher

Cardiovasc Diabetol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin.
Michael Stumvoll, Hans-Ulrich Häring, Stephan Matthaei

Endocr Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Consulting Prof. Dr. Stephan Matthaei. Quakenbrück diabetes center. Prescription relevant conclusions].
Stephan Matthaei

MMW Fortschr Med· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.
Andreas Pfützner, Thomas Schöndorf, Daniela Seidel, Karl Winkler, Stephan Matthaei

Metabolism· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.
Andreas Hamann, Stephan Matthaei, Christoph Rosak, Louise Silvestre,

Diabetes Care· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[National practice guidelines. New aspects in therapy of type 2 diabetes mellitus].
Axel Haupt, Hans-Ulrich Häring, Stephan Matthaei

MMW Fortschr Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide.
Axel Haupt, Christiana Kausch, Dominik Dahl, Oliver Bachmann, Michael Stumvoll, Stephan Matthaei

Diabetes Care· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis